Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' ESMON CT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 135 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Esmon, CT
      The normal role of Activated Protein C in maintaining homeostasis and its relevance to critical illness

      CRITICAL CARE
    2. Alberio, L; Lammle, B; Esmon, CT
      Protein C replacement in severe meningococcemia: Rationale and clinical experience

      CLINICAL INFECTIOUS DISEASES
    3. Alberio, L; Lammle, B; Esmon, CT
      Protein C replacement in severe meningococcemia: rationale and clinical experience ( vol 32, pg 1338, 2001)

      CLINICAL INFECTIOUS DISEASES
    4. Biguzzi, E; Merati, G; Liaw, PCY; Bucciarelli, P; Oganesyan, N; Qu, DF; Gu, JM; Fetiveau, R; Esmon, CT; Mannucci, PM; Faioni, EM
      A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairsEPCR function

      THROMBOSIS AND HAEMOSTASIS
    5. Esmon, CT
      Role of coagulation inhibitors in inflammation

      THROMBOSIS AND HAEMOSTASIS
    6. Esmon, CT
      Protein C anticoagulant pathway and its role in controlling microvascular thrombosis and inflammation

      CRITICAL CARE MEDICINE
    7. Faust, SN; Levin, M; Harrison, OB; Goldin, RD; Lockhart, MS; Kondaveeti, S; Laszik, Z; Esmon, CT; Heyderman, RS
      Dysfunction of endothelial protein C activation in severe meningococcal sepsis.

      NEW ENGLAND JOURNAL OF MEDICINE
    8. Safa, O; Hensley, K; Smirnov, MD; Esmon, CT; Esmon, NL
      Lipid oxidation enhances the function of activated protein C

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Liaw, PCY; Mather, T; Oganesyan, N; Ferrell, GL; Esmon, CT
      Identification of the protein C/activated protein C finding sites on the endothelial cell protein C receptor - Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Taylor, FB; Peer, GT; Lockhart, MS; Ferrell, G; Esmon, CT
      Endothelial cell protein C receptor plays an important role in protein C activation in vivo

      BLOOD
    11. Wang, SX; Esmon, CT; Fletterick, RJ
      Crystal structure of thrombin-ecotin reveals conformational changes and extended interactions

      BIOCHEMISTRY
    12. Laszik, ZG; Zhou, XJ; Ferrell, GL; Silva, FG; Esmon, CT
      Down-regulation of endothelial expression of endothelial cell protein C receptor and thrombomodulin in coronary atherosclerosis

      AMERICAN JOURNAL OF PATHOLOGY
    13. Esmon, CT
      The anticoagulant and anti-inflammatory roles of the protein C anticoagulant pathway

      JOURNAL OF AUTOIMMUNITY
    14. Esmon, NL; Safa, O; Smirnov, MD; Esmon, CT
      Antiphospholipid antibodies and the protein C pathway

      JOURNAL OF AUTOIMMUNITY
    15. Esmon, CT
      The endothelial cell protein C receptor

      THROMBOSIS AND HAEMOSTASIS
    16. Carson, CW; Comp, PC; Rezaie, AR; Esmon, NL; Esmon, CT
      Antibodies to thrombomodulin are found in patients with lupus anticoagulant and unexplained thrombosis

      JOURNAL OF RHEUMATOLOGY
    17. Esmon, CT
      Does inflammation contribute to thrombotic events?

      HAEMOSTASIS
    18. Esmon, CT
      Regulation of blood coagulation

      BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    19. Kurosawa, S; Esmon, CT; Stearns-Kurosawa, DJ
      The soluble endothelial protein C receptor binds to activated neutrophils:Involvement of proteinase-3 and CD11b/CD18

      JOURNAL OF IMMUNOLOGY
    20. Liaw, PCY; Neuenschwander, PF; Smirnov, MD; Esmon, CT
      Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Xu, J; Qu, DF; Esmon, NL; Esmon, CT
      Metalloproteolytic release of endothelial cell protein C receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Gu, JM; Fukudome, K; Esmon, CT
      Characterization and regulation of the 5 '-flanking region of the murine endothelial protein C receptor gene

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Taylor, FB; Stearns-Kurosawa, DJ; Kurosawa, S; Ferrell, G; Chang, ACK; Laszik, Z; Kosanke, S; Peer, G; Esmon, CT
      The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis

      BLOOD
    24. Gu, JM; Katsuura, Y; Ferrell, GL; Grammas, P; Esmon, CT
      Endotoxin and thrombin elevate rodent endothelial cell protein C receptor mRNA levels and increase receptor shedding in vivo

      BLOOD
    25. Alberio, L; Safa, O; Clemetson, KJ; Esmon, CT; Dale, GL
      Surface expression and functional characterization of alpha-granule factorV in human platelets: effects of ionophore A23187, thrombin, collagen, andconvulxin

      BLOOD
    26. Esmon, CT
      Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?

      BLOOD
    27. Perera, L; Foley, C; Darden, TA; Stafford, D; Mather, T; Esmon, CT; Pedersen, LG
      Modeling zymogen protein C

      BIOPHYSICAL JOURNAL
    28. Esmon, CT
      Possible involvement of cytokines in diffuse intravascular coagulation andthrombosis

      BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
    29. Esmon, NL; Smirnov, MD; Safa, O; Esmon, CT
      Lupus anticoagulants, thrombosis and the protein C system

      HAEMATOLOGICA
    30. Esmon, CT; Gu, JM; Xu, J; Qu, DF; Stearns-Kurosawa, DJ; Kurosawa, S
      Regulation and functions of the protein C anticoagulant pathway

      HAEMATOLOGICA
    31. Esmon, CT; Fukudome, K; Mather, T; Bode, W; Regan, LM; Stearns-Kurosawa, DJ; Kurosawa, S
      Inflammation, sepsis, and coagulation

      HAEMATOLOGICA
    32. Esmon, CT; Xu, J; Gu, JM; Qu, DF; Laszik, Z; Ferrell, G; Stearns-Kurosawa, DJ; Kurosawa, S; Taylor, FB; Esmon, NL
      Endothelial protein C receptor

      THROMBOSIS AND HAEMOSTASIS
    33. Esmon, CT
      Natural anticoagulants and their pathways

      ANTITHROMBOTICS
    34. Yegneswaran, S; Smirnov, MD; Safa, O; Esmon, NL; Esmon, CT; Johnson, AE
      Relocating the active site of activated protein C eliminates the need for its protein S cofactor - A fluorescence resonance energy transfer study

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. Xu, J; Esmon, NL; Esmon, CT
      Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation

      JOURNAL OF BIOLOGICAL CHEMISTRY
    36. Smirnov, MD; Safa, O; Esmon, NL; Esmon, CT
      Inhibition of activated protein C anticoagulant activity by prothrombin

      BLOOD
    37. Safa, O; Morrissey, JH; Esmon, CT; Esmon, NL
      Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C

      BIOCHEMISTRY
    38. Smirnov, MD; Ford, DA; Esmon, CT; Esmon, NL
      The effect of membrane composition on the hemostatic balance

      BIOCHEMISTRY
    39. ESMON CT
      INFLAMMATION AND THROMBOSIS MUTUAL REGULATION BY PROTEIN-C

      Immunologist
    40. ESMON CT; MATHER T
      SWITCHING SERINE-PROTEASE SPECIFICITY

      Nature structural biology
    41. SMIRNOV MD; SAFA O; REGAN L; MATHER T; STEARNSKUROSAWA DJ; KUROSAWA S; REZAIE AR; ESMON NL; ESMON CT
      A CHIMERIC PROTEIN-C CONTAINING THE PROTHROMBIN GLA DOMAIN EXHIBITS INCREASED ANTICOAGULANT ACTIVITY AND ALTERED PHOSPHOLIPID SPECIFICITY

      The Journal of biological chemistry
    42. HARKER LA; MARZEC UM; MOHRI M; FERNANDEZ JA; KELLY AB; HANSON SR; ESMON CT; GRIFFIN JH
      RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN INHIBITION OF THROMBUS FORMATION IN NONHUMAN-PRIMATES

      Circulation
    43. KUROSAWA S; STEARNSKUROSAWA DJ; CARSON CW; DANGELO A; DELLAVALLE P; ESMON CT
      PLASMA-LEVELS OF ENDOTHELIAL-CELL PROTEIN-C RECEPTOR ARE ELEVATED IN PATIENTS WITH SEPSIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS - LACK OF CORRELATION WITH THROMBOMODULIN SUGGESTS INVOLVEMENT OF DIFFERENT PATHOLOGICAL PROCESSES

      Blood
    44. REZAIE AR; HE XH; ESMON CT
      THROMBOMODULIN INCREASES THE RATE OF THROMBIN INHIBITION BY BPTI

      Biochemistry
    45. ESMON CT; FUKUDOME K; MATHER T; BODE W; ESMON NL; REGAN LM; STEARNSKUROSAWA DJ; KUROSAWA S
      INFLAMMATION - THE PROTEIN-C PATHWAY

      Fibrinolysis & proteolysis
    46. GU JM; ESMON CT
      FUNCTIONAL-CHARACTERIZATION OF 5'-FLANKING REGION OF THE MOUSE ENDOTHELIAL PROTEIN-C RECEPTOR (EPCR) GENE

      Molecular biology of the cell
    47. MARTIN PD; MALKOWSKI MG; BOX J; ESMON CT; EDWARDS BFP
      NEW INSIGHTS INTO THE REGULATION OF THE BLOOD-CLOTTING CASCADE DERIVED FROM THE X-RAY CRYSTAL-STRUCTURE OF BOVINE MEIZOTHROMBIN DES F1 IN COMPLEX WITH PPACK

      Structure
    48. AHMAD MF; STROKA D; GREY S; BACH FH; ESMON CT; HANCOCK WW
      CLONING OF ENDOTHELIAL PROTEIN-C RECEPTOR (EPCR) FROM HUMAN MONOCYTES

      The FASEB journal
    49. ESMON NL; SMIRNOV MD; ESMON CT
      LUPUS ANTICOAGULANTS AND THROMBOSIS - THE ROLE OF PHOSPHOLIPIDS

      Haematologica
    50. ESMON CT; DING W; YASUHIRO K; GU JM; FERRELL G; REGAN LM; STEARNSKUROSAWA DJ; KUROSAWA S; MATHER T; LASZIK Z; ESMON NL
      THE PROTEIN-C PATHWAY - NEW INSIGHTS

      Thrombosis and haemostasis
    51. ESMON NL; SMIRNOV MD; ESMON CT
      THROMBOGENIC MECHANISMS OF ANTIPHOSPHOLIPID ANTIBODIES

      Thrombosis and haemostasis
    52. REGAN LM; MOLLICA J; REZAIE AR; ESMON CT
      THE INTERACTION BETWEEN THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR AND PROTEIN-C IS DICTATED BY THE GLA DOMAIN OF PROTEIN-C

      Thrombosis and haemostasis
    53. COOPER ST; REZAIE AR; ESMON CT; CHURCH FC
      ROLE OF ANION-BINDING EXOSITE-2 OF THROMBIN DURING GLYCOSAMINOGLYCAN-CATALYZED INHIBITION OF PROTEIN-C INHIBITOR AND HEPARIN-COFACTOR-II

      Thrombosis and haemostasis
    54. VANDELOCHT A; BODE W; HUBER R; LEBONNIEC BF; STONE SR; ESMON CT; STUBBS MT
      THE THROMBIN E192Q-BPTI COMPLEX REVEALS GROSS STRUCTURAL REARRANGEMENTS - IMPLICATIONS FOR THE INTERACTION WITH ANTITHROMBIN AND THROMBOMODULIN

      EMBO journal
    55. KUROSAWA S; STEARNSKUROSAWA DJ; HIDARI N; ESMON CT
      IDENTIFICATION OF FUNCTIONAL ENDOTHELIAL PROTEIN-C RECEPTOR IN HUMAN PLASMA

      The Journal of clinical investigation
    56. REGAN LM; MOLLICA JS; REZAIE AR; ESMON CT
      THE INTERACTION BETWEEN THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR AND PROTEIN-C IS DICTATED BY THE GAMMA-CARBOXYGLUTAMIC ACID DOMAIN OF PROTEIN-C

      The Journal of biological chemistry
    57. YEGNESWARAN S; WOOD GM; ESMON CT; JOHNSON AE
      PROTEIN-S ALTERS THE ACTIVE-SITE LOCATION OF ACTIVATED PROTEIN-C ABOVE THE MEMBRANE-SURFACE - A FLUORESCENCE RESONANCE ENERGY-TRANSFER STUDY OF TOPOGRAPHY

      The Journal of biological chemistry
    58. HOUSTON DS; CARSON CW; ESMON CT
      ENDOTHELIAL-CELLS AND EXTRACELLULAR CALMODULIN INHIBIT MONOCYTE TUMOR-NECROSIS-FACTOR RELEASE AND AUGMENT NEUTROPHIL ELASTASE RELEASE

      The Journal of biological chemistry
    59. KUROSAWA S; STEARNSKUROSAWA DJ; HIDARI N; CARSON CW; ESMON CT
      SOLUBLE ENDOTHELIAL PROTEIN-C RECEPTOR IN HUMAN PLASMA

      Circulation
    60. REZAIE AR; HE XH; ESMON CT
      THROMBOMODULIN INCREASES THE RATE OF THROMBIN INHIBITION BY BPTI

      Circulation
    61. MUZYKANTOV VR; BALYASNIKOVA IV; FISHER AB; SMIRNOV MD; ESMON NL; ESMON CT
      ENDOTHELIAL-CELLS SELECTIVELY INTERNALIZE MONOCLONAL-ANTIBODY REACTING WITH CHONDROITIN SULFATE-FREE THROMBOMODULIN

      Circulation
    62. SMIRNOV MD; ESMON NL; ESMON CT
      EFFECT OF MEMBRANE PHOSPHOLIPID-COMPOSITION AND ANTIPHOSPHOLIPID ANTIBODY ON THE HEMOSTATIC BALANCE

      Circulation
    63. ESMON CT; LASZIK Z; MITRO A; TAYLOR FB; FERRELL G
      THE HUMAN PROTEIN-C RECEPTOR IS PRESENT PRIMARILY ON ENDOTHELIUM OF LARGE BLOOD-VESSELS - IMPLICATIONS FOR THE CONTROL OF THE PROTEIN-C PATHWAY

      Circulation
    64. LASZIK Z; MITRO A; TAYLOR FB; FERRELL G; ESMON CT
      HUMAN PROTEIN-C RECEPTOR IS PRESENT PRIMARILY ON ENDOTHELIUM OF LARGEBLOOD-VESSELS - IMPLICATIONS FOR THE CONTROL OF THE PROTEIN-C PATHWAY

      Circulation
    65. ESMON CT
      DEFECTS IN NATURAL ANTICOAGULANT PATHWAYS AS POTENTIAL RISK-FACTORS FOR MYOCARDIAL-INFARCTION

      Circulation
    66. OREGAN DJ; BRENNAND D; ESMON CT; GOODWIN CA; KAKKAR VV; SCULLY MF
      SPECIFIC BINDING OF ACTIVATED PROTEIN-C (APC) TO VASCULAR SMOOTH-MUSCLE CELLS IS NOT DUE TO THE ENDOTHELIAL RECEPTOR (EPCR)

      Blood
    67. AHMAD MF; BACH FH; ESMON CT; HANCOCK WW
      CLONING AND IN-VITRO ANALYSIS OF THE ENDOTHELIAL PROTEIN-C RECEPTOR (EPCR) ON HUMAN MONOCYTES SHOW THAT MONOCYTE EPCR DOES NOT MEDIATE THE ANTIINFLAMMATORY EFFECTS OF ACTIVATED PROTEIN-C

      Blood
    68. YEGNESWARAN S; SMIRNOV MD; ESMON NL; ESMON CT; JOHNSON AE
      RELOCATION OF THE ACTIVE-SITE OF ACTIVATED PROTEIN-C CLOSER TO THE MEMBRANE-SURFACE COINCIDES WITH AN INCREASE IN FACTOR VA INACTIVATION ACTIVITY AND AN INSENSITIVITY TO PROTEIN-S STIMULATION OF ACTIVITY

      Blood
    69. TAYLOR FB; COLLER BS; CHANG ACK; PEER G; JORDAN R; ENGELLENER W; ESMON CT
      7E3 F(AB')(2), A MONOCLONAL-ANTIBODY TO THE PLATELET GPIIB IIIA RECEPTOR, PROTECTS AGAINST MICROANGIOPATHIC HEMOLYTIC-ANEMIA AND MICROVASCULAR THROMBOTIC RENAL-FAILURE IN BABOONS TREATED WITH C4B BINDING-PROTEIN AND A SUBLETHAL INFUSION OF ESCHERICHIA-COLI/

      Blood
    70. HE XH; YE J; ESMON CT; REZAIE AR
      INFLUENCE OF ARGININE-93, ARGININE-97, AND ARGININE-101 OF THROMBIN TO ITS FUNCTIONAL SPECIFICITY

      Biochemistry
    71. YEGNESWARAN S; WOOD GM; ESMON CT; JOHNSON AE
      ACTIVATED PROTEIN-C BINDING TO MEMBRANES DOES NOT REQUIRE NEGATIVELY-CHARGED PHOSPHOLIPIDS

      The FASEB journal
    72. BAUMAN SJ; REZAIE AR; ESMON CT; CHURCH FC
      INTERACTION OF THROMBIN-60-INSERTION LOOP MUTANTS WITH ANTITHROMBIN, HEPARIN-COFACTOR-II AND HIRUDIN

      The FASEB journal
    73. TAYLOR FB; HE SE; CHANG ACK; BOX J; FERRELL G; LEE D; LOCKHART M; PEER G; ESMON CT
      INFUSION OF PHOSPHOLIPID-VESICLES AMPLIFIES THE LOCAL THROMBOTIC RESPONSE TO TNF AND ANTI-PROTEIN-C INTO A CONSUMPTIVE RESPONSE

      Thrombosis and haemostasis
    74. ESMON CT
      FUNCTIONS AND REGULATION OF THE PROTEIN-C ANTICOAGULANT PATHWAY

      Experimental hematology
    75. STEARNSKUROSAWA DJ; KUROSAWA S; MOLLICA JS; FERRELL GL; ESMON CT
      THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR AUGMENTS PROTEIN-C ACTIVATIONBY THE THROMBIN-THROMBOMODULIN COMPLEX

      Proceedings of the National Academy of Sciences of the United Statesof America
    76. FUKUDOME K; KUROSAWA S; STEARNSKUROSAWA DJ; HE XH; REZAIE AR; ESMON CT
      THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR - CELL-SURFACE EXPRESSION ANDDIRECT LIGAND-BINDING BY THE SOLUBLE RECEPTOR

      The Journal of biological chemistry
    77. REGAN LM; STEARNSKUROSAWA DJ; KUROSAWA S; MOLLICA J; FUKUDOME K; ESMON CT
      THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR - INHIBITION OF ACTIVATED PROTEIN-C ANTICOAGULANT FUNCTION WITHOUT MODULATION OF REACTION WITH PROTEINASE-INHIBITORS

      The Journal of biological chemistry
    78. ESMON CT; LOLLAR P
      INVOLVEMENT OF THROMBIN ANION-BINDING EXOSITE-1 AND EXOSITE-2 IN THE ACTIVATION OF FACTOR-V AND FACTOR-VIII

      The Journal of biological chemistry
    79. REZAIE AR; ESMON CT
      MOLECULAR-BASIS OF RESIDUE-192 PARTICIPATION IN DETERMINATION OF COAGULATION PROTEASE SPECIFICITY

      European journal of biochemistry
    80. SMIRNOV M; REZAIE AR; REGAN LM; ESMON CT; ESMON NL
      THE PE DEPENDENCE OF ACTIVATED PROTEIN-C FUNCTION IS MEDIATED THROUGHTHE GLA-DOMAIN

      Circulation
    81. KUROSAWA S; FUKUDOME K; STEARNSKUROSAWA D; MOLLICA J; FERRELL G; HIDARI N; ESMON CT
      THE ENDOTHELIAL-CELL PROTEIN-C RECEPTOR PARTICIPATES IN PROTEIN-C ACTIVATION

      Circulation
    82. DING W; GU JM; FUKUDOME K; LASZIK Z; GRAMMAS P; ESMON CT
      UP-REGULATION OF THE MESSAGE FOR RODENT ENDOTHELIAL-CELL PROTEIN-C RECEPTOR (EPCR) BY ENDOTOXIN AND THROMBIN

      Circulation
    83. TAYLOR FB; ESMON CT; CHANG ACK; PEER G; JORDAN R; ENGELLENNER W; COLLER BS
      THROMBOPOIETIN (TPO) UPTAKE WITHIN THE SPLEEN IS PRIMARILY RESPONSIBLE FOR LOWERING CIRCULATING TPO LEVELS IN IMMUNE THROMBOCYTOPENIC HOSTS

      Blood
    84. TAYLOR FB; ESMON CT; CHANG ACK; PEER G; JORDAN R; ENGELLENNER W; COLLER BS
      PLATELET GPIIB IIIA RECEPTOR BLOCKADE BY 7E3 F(AB')(2) PROTECTS AGAINST MICROANGIOPATHIC HEMOLYTIC-ANEMIA AND MICROVASCULAR THROMBOTIC RENAL-FAILURE IN BABOONS TREATED WITH C4B BINDING-PROTEIN AND A SUBLETHAL INFUSION OF ESCHERICHIA-COLI/

      Blood
    85. HE X; ESMON CT; REZAIE AR
      INFLUENCE OF ARG93, ARG97 AND ARG101 OF THROMBIN TO SPECIFICITY

      Blood
    86. ESMON CT; SCHWARZ HP
      AN UPDATE ON CLINICAL AND BASIC ASPECTS OF THE PROTEIN-C ANTICOAGULANT PATHWAY

      Trends in cardiovascular medicine
    87. ESMON CT
      CELLULAR-REGULATION OF BLOOD-COAGULATION - INTRODUCTION

      Seminars in cell biology
    88. ESMON CT; FUKUDOME K
      CELLULAR-REGULATION OF THE PROTEIN-C PATHWAY

      Seminars in cell biology
    89. ESMON CT
      INFLAMMATION - THEYRE NOT JUST FOR CLOTS ANYMORE

      Current biology
    90. ESMON CT
      THROMBOMODULIN AS A MODEL OF MOLECULAR MECHANISMS THAT MODULATE PROTEASE SPECIFICITY AND FUNCTION AT THE VESSEL SURFACE

      The FASEB journal
    91. SMIRNOV MD; TRIPLETT DT; COMP PC; ESMON NL; ESMON CT
      ON THE ROLE OF PHOSPHATIDYLETHANOLAMINE IN THE INHIBITION OF ACTIVATED PROTEIN-C ACTIVITY BY ANTIPHOSPHOLIPID ANTIBODIES

      The Journal of clinical investigation
    92. REZAIE AR; COOPER ST; CHURCH FC; ESMON CT
      PROTEIN-C INHIBITOR IS A POTENT INHIBITOR OF THE THROMBIN-THROMBOMODULIN COMPLEX

      The Journal of biological chemistry
    93. REZAIE AR; ESMON CT
      CONTRIBUTION OF RESIDUE-192 IN FACTOR-XA TO ENZYME SPECIFICITY AND FUNCTION

      The Journal of biological chemistry
    94. FUKUDOME K; ESMON CT
      MOLECULAR-CLONING AND EXPRESSION OF MURINE AND BOVINE ENDOTHELIAL-CELL PROTEIN C ACTIVATED PROTEIN-C RECEPTOR (EPCR) - THE STRUCTURAL AND FUNCTIONAL CONSERVATION IN HUMAN, BOVINE, AND MURINE EPCR/

      The Journal of biological chemistry
    95. TAYLOR FB; DAHLBACK B; CHANG ACK; LOCKHART MS; HATANAKA K; PEER G; ESMON CT
      ROLE OF FREE PROTEIN-S AND C4B BINDING-PROTEIN IN REGULATING THE COAGULANT RESPONSE TO ESCHERICHIA-COLI

      Blood
    96. FUKUDOME K; KUROSAWA S; STERNSKUROSAWA DJ; REGAN L; ESMON CT
      CELL-SURFACE EXPRESSION OF THE ENDOTHELIAL-CELL PROTEIN-C ACTIVATED PROTEIN-C RECEPTOR (EPCR)

      Blood
    97. REGAN L; REZAIE AR; FUKUDOME K; STEARNSKUROSAWA DJ; KUROSAWA S; MOLLICA J; ESMON CT
      EVIDENCE FOR A FREE SULFHYDRYL (S) IN THE ENDOTHELIAL-CELL PROTEIN-C ACTIVATED PROTEIN-C RECEPTOR (EPCR)

      Blood
    98. YEGNESWARAN S; WOOD GM; ESMON CT; JOHNSON AE
      PROTEIN-S ALTERS THE DISTANCE BETWEEN THE ACTIVE-SITE OF ACTIVATED PROTEIN-C AND THE MEMBRANE-SURFACE

      Blood
    99. HOUSTON DS; CARSON CW; ESMON CT
      IDENTIFICATION OF A MONOCYTIC CELL-SURFACE RECEPTOR THAT RECOGNIZES EXTRACELLULAR CALMODULIN, AN ANTIINFLAMMATORY MEDIATOR RELEASED FROM ENDOTHELIAL-CELLS

      Blood
    100. REZAIE AR; COOPER ST; CHURCH FC; ESMON CT
      PROTEIN-C INHIBITOR IS A POTENT INHIBITOR OF THE THROMBIN-THROMBOMODULIN COMPLEX

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 02:14:39